10-K: ALX Oncology Details Share Structure and Registration Rights in 10-K Filing

ALX Oncology's 10-K filing outlines the company's capital structure, including common and preferred stock, and details registration rights for certain shareholders.

Summary

• ALX Oncology's authorized capital stock consists of 1,000,000,000 shares of common stock and 100,000,000 shares of convertible preferred stock, both with a par value of $0.001 per share.
• The company has one class of securities registered under Section 12 of the Securities and Exchange Act of 1934, which is its common stock, listed on the Nasdaq Global Select Market under the symbol ALXO.
• Holders of common stock are entitled to one vote per share on all matters submitted to a vote of the stockholders, and the company does not provide for cumulative voting rights.
• The board of directors is authorized to issue up to 100,000,000 shares of preferred stock in one or more series, with rights, preferences, and privileges that may be greater than those of common stock.
• Certain holders of common stock have demand, S-3, and piggyback registration rights, allowing them to sell their shares under certain conditions.
• The company is obligated to indemnify holders of registrable securities for material misstatements or omissions in the registration statement attributable to the company, and vice versa.
• The demand, S-3, and piggyback registration rights will expire upon the earliest of (1) the fifth anniversary after the closing of the initial public offering, (2) a deemed liquidation event, and (3) such time after the completion of the initial public offering that such stockholder can sell all of its shares entitled to registration rights under Rule 144 of the Securities Act.
• The company's board of directors is divided into three classes, with directors serving staggered three-year terms.
• Stockholders may only remove a director for cause by a vote of no less than a majority of the shares present in person or by proxy at the meeting and entitled to vote.
• The company's bylaws provide that the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for certain legal actions.
• The federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act.
• The company is governed by Section 203 of the DGCL, which restricts business combinations with interested stockholders for a period of three years following the time that such stockholder became an interested stockholder, unless certain conditions are met.
• The company must indemnify its directors and officers to the fullest extent authorized by the DGCL and carries directors and officers insurance.
• The company's common stock is listed on the Nasdaq Global Select Market under the symbol ALXO.
• The transfer agent and registrar for the company's common stock is Computershare Trust Company, N.A.

Sentiment

Score: 5

Explanation: The document is neutral, providing factual information about the company's capital structure and governance. There is no positive or negative sentiment.

Positives

• The company has a clear structure for its common and preferred stock.
• Registration rights provide liquidity options for certain shareholders.
• The staggered board structure provides continuity.
• Indemnification and insurance for directors and officers offer protection.
• Listing on the Nasdaq Global Select Market provides visibility.

Negatives

• The board's ability to issue preferred stock could dilute common stock voting power.
• Anti-takeover provisions may deter potential acquisitions.
• Exclusive forum provisions may limit stockholders' ability to choose a favorable legal venue.
• Section 203 of the DGCL may restrict business combinations.

Risks

• The issuance of preferred stock could adversely affect the voting power of common stockholders.
• The rights of common stockholders are subject to the rights of preferred stockholders.
• Anti-takeover provisions may delay or prevent a change in control.
• Exclusive forum provisions may discourage lawsuits against the company.
• The company's indemnification provisions may discourage lawsuits against directors.
• The company's authorized but unissued shares may discourage an attempt to obtain control of the company.

Future Outlook

The company has no present plan to issue any shares of preferred stock.

Industry Context

This document is a standard description of securities for a publicly traded company, and the details are typical for a company listed on the Nasdaq.

Comparison to Industry Standards

• The capital structure described is typical for a publicly traded biotechnology company.
• The registration rights are standard for venture-backed companies.
• The anti-takeover provisions are common in Delaware corporations.
• The indemnification and insurance provisions are standard for public companies.
• The exclusive forum provisions are increasingly common in corporate bylaws.

Corporate Governance

Stakeholder Impact

• Shareholders: The document outlines their voting rights and potential dilution.
• Potential Investors: The document provides information about the company's capital structure and governance.
• Directors and Officers: The document outlines their indemnification and insurance coverage.

Key Dates

Keywords

common stock, preferred stock, registration rights, voting rights, board of directors, Delaware General Corporation Law, Nasdaq, indemnification, anti-takeover, corporate governance